| 查看: 508 | 回复: 0 | |||
[交流]
美国休斯顿卫理公会医院肿瘤中心诚招肿瘤分子生物学博后
|
|
One postdoctoral position is available involved in molecular mechanism research of tumor microenvironment in Dr. Jing Yang’s lab at the Houston Methodist Cancer Center. The candidate will be responsible for the projects to identify new biomarkers or therapeutic targets within the bone marrow microenvironment of multiple myeloma for better prevention, diagnosis, or therapy improvement. The translational research program at Dr. Yang’s lab aims to investigate the interplay between cancer cells and bone marrow stromal cells such as adipocytes, immune cells, and bone cells. And the association between obesity and cancer. These studies explore innovative approaches or strategies to prevent therapeutic resistance and improve chemo and immunotherapeutic efficacy and early detection of hematological malignancies. Please refer to the selected publications from Dr. Yang’s lab for more information (Science Translational Medicine (2016, PMID: 27559096); Science Translational Medicine (2019, PMID: 31142679); Cell Metabolism (2021, PMID: 33406405); Nature Communication (2022, PMID: 35760800). We seek a highly motivated and independent candidate with a recent Ph.D. and/or M.D. degree in one of the following (or relevant) areas: oncology, cancer metabolism, or immunology. A candidate with a strong molecular biology background is preferred. The position is opening now until filled. The pay scale follows the NIH guidelines. Interested applications, including curriculum vitae, a brief cover letter, and the contact information of three references should be sent to Dr.Yang: jyang2@houstonmethodist.org. Jing Yang, PhD Associate professor Houston Methodist Cancer Center Weill Cornell Medical College 6550 Fannin St., SM8-023 Houston, TX 77030 |
» 猜你喜欢
2026年申博-电池方向
已经有3人回复
2026年博士申请求捞
已经有5人回复
26年博士申请自荐-电催化
已经有9人回复
申博自荐
已经有9人回复
研究生做的很差,你们会让毕业吗?
已经有11人回复
求碳排放博导;方向是LCA、生命周期可持续发展以及碳排放
已经有7人回复
2026博士申请求助
已经有4人回复
2026博士或科研助理转27年博士
已经有7人回复
急招2026年9月份入学博士
已经有3人回复
国自科送审了吗
已经有11人回复












回复此楼